Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $.0001 per share
Symbol
VOR on Nasdaq
Shares outstanding
6,871,602
Price per share
$1.52
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-57,026,224
Value change
-$91,784,568
Number of holders
0
Price from insider filings
$1.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 32% -0.31% $5,960,978 +$4,500 39,739,850 +0.08% RA Capital Management, L.P. 25 Jun 2025
5AM Ventures VI, L.P. 3.5% $663,429 4,422,863 Andrew J. Schwab 08 Jul 2025
FMR LLC 1.7% -68% $313,903 -$649,472 2,092,686 -67% FMR LLC 30 Jun 2025
Reprogrammed Interchange LLC 19% -7.5% $1,942,739 -$146,919 1,278,118 -7% Reprogrammed Interchange LLC 14 Oct 2025

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR). This represents 0% of the company’s total 6,871,602 outstanding shares.

Institutional Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$91,784,568 $1.52 0
2025 Q2 57,027,241 $91,786,194 -$3,748,592 $1.62 33
2025 Q1 60,090,600 $43,114,461 -$1,211,901 $0.72 44
2024 Q4 60,946,605 $67,648,215 +$16,089,560 $1.11 51
2024 Q3 47,833,716 $33,482,802 -$6,822,571 $0.70 53
2024 Q2 54,508,628 $54,505,617 -$7,861,040 $1.00 67
2024 Q1 58,931,375 $139,665,734 -$1,222,722 $2.37 67
2023 Q4 15,894 $35,762 $2.25 1
2023 Q3 60,212,841 $127,651,455 -$1,545,100 $2.12 59
2023 Q2 60,773,643 $187,787,171 -$4,654,845 $3.09 70
2023 Q1 60,544,099 $325,727,180 +$1,560,332 $5.38 60
2022 Q4 60,203,525 $400,322,462 +$190,933,249 $6.65 58
2022 Q3 31,524,229 $125,476,000 +$1,517,973 $3.98 42
2022 Q2 31,117,983 $154,651,746 +$350,683 $4.97 43
2022 Q1 30,978,950 $187,113,000 -$1,512,921 $6.04 50
2021 Q4 31,126,669 $361,728,757 -$5,702,681 $11.62 57
2021 Q3 27,482,087 $430,919,720 +$3,128,507 $15.68 50
2021 Q2 30,771,027 $571,152,000 -$547,389 $18.65 51
2021 Q1 30,710,467 $1,311,814,993 +$1,311,814,626 $43.10 49